PFO closure in Asia: current evidence, emerging indications and future directions
Friday, July 24, 2026 13:00 CEST / 19:00 Beijing time
Moderators:
Bernhard Meier, University Bern, Switzerland
Ronen Gurvitch, Royal Melbourne Hospital, Victoria, Australia
PROGRAM
PFO: have we truly understood its clinical and biological significance? >> Zhang Zhe, Peking University Third Hospital, Beijing, China
PFO closure: from controversy to standard of care – lessons from three decades >> Bernhard Meier, University Bern, Switzerland
Migraine and PFO closure: insights from China's rapidly growing experience >> Jiang Xiaofei, Zhuhai People's Hospital, Guangdong Province, China
Pre-procedure assessment: why TCD matters >> Brian Chambers, Austin Hospital, Heidelberg, Australia
Heart-brain team is the way to go: a stroke neurologist's perspective >> Vijay Kumar Sharma, National University Hospital, Singapore
Preserving future septal access: should we be moving toward biodegradable occluders? >> Hidehiko Hara, Toho University Ohashi Medical Center, Tokyo, Japan
Supported by:
Accredited for 2 EBAC credits
This program is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 2 hours of effective education time. EBAC® holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively. Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™. EBAC® is a member of the International Academy for CPD Accreditation (IACPDA) and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).